Lv1
54 积分 2025-03-07 加入
Androgen receptor pathway inhibitors and drug–drug interactions in prostate cancer
21天前
已完结
Current androgen receptor antagonists under investigation for resistant prostate cancer
21天前
已完结
Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia
22天前
已完结
PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
22天前
已完结
Discovery of Potential First-in-Class Dual Ligand-Directed Degrader and Antagonist of the Androgen Receptor: BMS-986365
22天前
已完结
Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia
23天前
已完结
Expanding the reach of molecular glue degraders
3个月前
已完结
DOI: https://doi.org/10.1371/journal.pbio.3000423
3个月前
已完结
The transmembrane domains of GPCR dimers as targets for drug development
3个月前
已完结
Amylin receptor subunit interactions are modulated by agonists and determine signaling
4个月前
已完结
皖公网安备34019202002308
